These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Schröder J; Silvestri S; Bubeck B; Karr M; Demisch S; Scherrer S; Geider FJ; Sauer H Biol Psychiatry; 1998 May; 43(9):660-5. PubMed ID: 9582999 [TBL] [Abstract][Full Text] [Related]
3. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197 [TBL] [Abstract][Full Text] [Related]
4. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects. Schlösser R; Schlegel S; Hiemke C; Nickel O; Bockisch A; Rao ML; Hahn K Psychiatry Res; 1997 Sep; 75(2):103-14. PubMed ID: 9351492 [TBL] [Abstract][Full Text] [Related]
5. Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study. Schröder J; Bubeck B; Silvestri S; Demisch S; Sauer H Psychiatry Res; 1997 Sep; 75(2):115-23. PubMed ID: 9351493 [TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study. Lomeña F; Catafau AM; Parellada E; Bernardo M; Font M; Gutiérrez F; Pavía J Psychopharmacology (Berl); 2004 Mar; 172(2):165-9. PubMed ID: 14624330 [TBL] [Abstract][Full Text] [Related]
13. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome]. Reiche W; Grundmann M; Huber G Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887 [TBL] [Abstract][Full Text] [Related]
14. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls. Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391 [TBL] [Abstract][Full Text] [Related]
15. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125 [TBL] [Abstract][Full Text] [Related]
16. Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs. Kuenstler U; Juhnhold U; Knapp WH; Gertz HJ Psychiatry Res; 1999 Feb; 90(1):31-9. PubMed ID: 10320209 [TBL] [Abstract][Full Text] [Related]
17. D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects. Scherer J; Tatsch K; Schwarz J; Oertel WH; Konjarczyk M; Albus M Acta Psychiatr Scand; 1994 Oct; 90(4):266-8. PubMed ID: 7831996 [TBL] [Abstract][Full Text] [Related]
19. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Kapur S; Zipursky R; Jones C; Remington G; Houle S Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409 [TBL] [Abstract][Full Text] [Related]